scholarly journals Operator Safety Zone During the Nitric Oxide Inhalation Vasoreactivity Test for Pulmonary Hypertension Patients

2017 ◽  
Vol 6 (0) ◽  
pp. 88-94
Author(s):  
Kanae Hashimoto ◽  
Akiyoshi Hashimoto ◽  
Masumi Kishimoto ◽  
Kosuke Sugawara ◽  
Hitomi Funahashi ◽  
...  
2018 ◽  
Vol 25 (6) ◽  
pp. 2174-2176
Author(s):  
Fayçal Ben Bouallègue ◽  
Fabien Vauchot ◽  
Aurélie Bourdon ◽  
Meriem Benkiran ◽  
Clément Boissin ◽  
...  

1999 ◽  
Vol 14 (3) ◽  
pp. 133-140 ◽  
Author(s):  
Jörg Weimann ◽  
Wolfgang Zink ◽  
Philipp A. Schnabel ◽  
Heinz Jakob ◽  
Martha Maria Gebhard ◽  
...  

2016 ◽  
Vol 12 (1) ◽  
Author(s):  
Khalid A Dahiyat

Background: Inhaled nitric oxide is a drug which has been given FDA approval in 1999 but was not found prior to approval to be safe for use in premature neonates. Aim: To review and assess the studies which was done prior to its approval in order to find out what evidences the approval by the FDA was based on. Methods: A thorough search of the electronic data-base, Medline, Embase, Cinahl, Google. Conclusion: The use of this drug in treatment of the Pulmonary hypertension in premature babies is still contraversial and hold a serious untoward effects on the health, it should only used as the last ditch.


Circulation ◽  
2000 ◽  
Vol 101 (17) ◽  
pp. 2066-2070 ◽  
Author(s):  
Toshio Hasuda ◽  
Toru Satoh ◽  
Akito Shimouchi ◽  
Fumio Sakamaki ◽  
Shingo Kyotani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document